Results 271 to 280 of about 216,439 (378)

Real-world evidence of imatinib treatment in younger and older patients with chronic myeloid leukaemia: A retrospective single centre analysis. [PDF]

Oncol Lett
Graf R, Kreye G, Pecherstorfer M, Singer J.   +3 more
europepmc   +1 more source

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides [PDF]

, 2004
Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth, Hans Skvara, Stefan Florian, Karoline Sonneck, Cahit Akgul, Sophia Derdak, Winfried F. Pickl, Volker Wacheck, Edgar Selzer, Brett P. Monia, Richard Moriggl, Peter Valent, Christian Sillaber   +14 more
openalex   +1 more source

Exploring cellular changes in ruptured human quadriceps tendons at single‐cell resolution

The Journal of Physiology, EarlyView.
Abstract figure legend This study explores the cellular landscape of healthy and ruptured quadriceps tendons using single nucleus RNA sequencing. While a range of stromal and immune cell types and subsets were identified, the data indicate that fibroblasts and endothelial cells are the main drivers of the early injury response within ruptured ...
Jolet Y. Mimpen, Mathew J. Baldwin, Claudia Paul, Lorenzo Ramos‐Mucci, Alina Kurjan, Carla J. Cohen, Shreeya Sharma, Marie S. N. Chevalier Florquin, Philippa A. Hulley, John McMaster, Andrew Titchener, Alexander Martin, Matthew L. Costa, Stephen E. Gwilym, Adam P. Cribbs, Sarah J. B. Snelling   +15 more
wiley   +1 more source

Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation. [PDF]

Ther Adv Hematol
Hafeez A, Shaikh MU, Hadi Mallick A, Nathani N, Alam J.   +4 more
europepmc   +1 more source

CML after treatment for lymphoid malignancy: Therapy‐related CML or coincidence?

, 2002
Javier Bolaños‐Meade, C Sarkodee-Adoo, Shyam L. Khanwani   +2 more
openalex   +1 more source

Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML [PDF]

, 2004
Thomas O’Hare, Roy M. Pollock, Eric P. Stoffregen, Jeffrey Keats, Omar Mohammed Abdullah, Erika M. Mosesón, Victor M. Rivera, Hao Tang, Chester A. Metcalf, Regine S. Bohacek, Yihan Wang, Raji Sundaramoorthi, William C. Shakespeare, David C. Dalgarno, Tim Clackson, Tomi K. Sawyer, Michael W. Deininger, Brian J. Druker   +17 more
openalex   +1 more source

Management of Late CML Relapse [PDF]

Biology of Blood and Marrow Transplantation, 2008
openaire   +3 more sources

Classical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis

American Journal of Hematology, Volume 100, Issue 8, Page 1283-1294, August 2025.
ABSTRACT Sinusoidal obstruction syndrome/veno‐occlusive disease (SOS/VOD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (allo‐HSCT). According to the 2016 European Society for Blood and Marrow Transplantation criteria, SOS/VOD is classified into classical SOS/VOD and late‐onset SOS/VOD, but their similarities and ...
Kyoko Masuda, Keisuke Kataoka, Masatoshi Sakurai, Yuho Najima, Naonori Harada, Shoko Ukita, Naoyuki Uchida, Noriko Doki, Takahiro Fukuda, Masatsugu Tanaka, Hiroyuki Ohigashi, Jun Ishikawa, Satoshi Yoshihara, Masashi Sawa, Shuichi Ota, Yoshinobu Kanda, Tetsuya Nishida, Makoto Onizuka, Yoshiko Atsuta, Hideki Nakasone, Kimikazu Yakushijin   +20 more
wiley   +1 more source

Current Advances in the Diagnosis and Treatment of Major Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Wang L, Li J, Arbitman L, Zhang H, Shao H, Martin M, Moscinski L, Song J.   +7 more
europepmc   +1 more source

Glivec: A New Treatment Modality for CML: A Case History

, 2002
J. Zimmermann
openalex   +1 more source